Richard Fields likes antitrust cases; so far he likes them to the tune of $79 million. Since late 2007, when he helped establish and float Juridica Capital Management on the London Stock Exchange’s junior market — raising $180 million in the process — Fields has been combing the American litigation market for commercial suits for his fund to invest in. Over the last three years, New York – based Juridica has sunk almost half of that money into five antitrust cases. Ferreting out the right antitrust case — that is, one in which liability has already been admitted — is as close to a sure thing as you can get in litigation financing, he boasts. The risk on liability “is typically very low [in these cases], especially in the United States, where there have been criminal convictions or plea agreements with the U.S. Department of Justice,” adds Fields, a former Dickstein Shapiro partner.
The antitrust cases haven’t produced a return yet. But some of the fund’s other investments have paid off nicely. Juridica generated gross proceeds of $2.4 million from its $1.5 million investment in a patent infringement case that recently settled. The fund also generated total gross proceeds of $24 million on four other cases that settled. The fund’s investment in those four cases was a combined $16.7 million. (Nondisclosure agreements prevent the fund from revealing more about its investments.)
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
